VANCOUVER, BC, June 18, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it has received approval to graduate to Tier 1 Issuer status on the TSX Venture Exchange (the “TSXV”), effective June 18, 2021. By qualifying for up…


Previous articlePTSF64 – The First Woman to Take Acid, The Drug Policy Reform Act, and Indigenous Language Extinction
Next articlePsychedelic Bulletin: atai IPOs on Nasdaq; Cybin to Target Anxiety Indications; Next Steps for California Decrim. Bill